Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553

Luigina Graziosi; Nicola Natalizi; Annibale Donini

doi:10.3390/jpm13060974

Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553

J Pers Med. 2023 Jun 9;13(6):974. doi: 10.3390/jpm13060974.

Authors

Luigina Graziosi¹, Nicola Natalizi¹, Annibale Donini¹

Affiliation

¹ Emergency and General Surgery, "Santa Maria della Misericordia" Hospital, University of Perugia, 06129 Perugia, Italy.

Abstract

I read with great interest the well-written and well-made study by Yi-Fu Chen et al. recently published in the "Journal of Personalized Medicine" [...].